Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

vTv Therapeutics (VTVT) Net Margin (2016 - 2025)

Historic Net Margin for vTv Therapeutics (VTVT) over the last 10 years, with Q4 2024 value amounting to 21376.47%.

  • vTv Therapeutics' Net Margin changed N/A to 21376.47% in Q4 2024 from the same period last year, while for Sep 2025 it was 138058.82%, marking a year-over-year decrease of 1362282200.0%. This contributed to the annual value of 1815.34% for FY2024, which is N/A changed from last year.
  • As of Q4 2024, vTv Therapeutics' Net Margin stood at 21376.47%.
  • In the past 5 years, vTv Therapeutics' Net Margin registered a high of 25.11% during Q4 2020, and its lowest value of 89562.5% during Q1 2020.
  • Over the past 4 years, vTv Therapeutics' median Net Margin value was 14066.01% (recorded in 2021), while the average stood at 26450.67%.
  • In the last 5 years, vTv Therapeutics' Net Margin crashed by -889237400bps in 2020 and then soared by 889604700bps in 2021.
  • vTv Therapeutics' Net Margin (Quarter) stood at 25.11% in 2020, then tumbled by -312064bps to 78344.44% in 2021, then soared by 33bps to 52722.22% in 2022, then skyrocketed by 59bps to 21376.47% in 2024.
  • Its Net Margin was 21376.47% in Q4 2024, compared to 486.5% in Q1 2024 and 52722.22% in Q4 2022.